Related Experiment Video
Updated: May 7, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Decrease in TSH levels after lactose restriction in Hashimoto's thyroiditis patients with lactose intolerance.
Endocrine
|October 1, 2013
Summary
High prevalence of lactose intolerance (LI) was found in Hashimoto
Area of Science:
- Endocrinology
- Gastroenterology
- Immunology
Background:
- Hashimoto's thyroiditis (HT) is an autoimmune disease.
- Lactose intolerance (LI) is common, but its prevalence in HT patients is not well-established.
- Thyroid function can be influenced by various dietary factors.
Purpose of the Study:
- To determine the prevalence of LI in HT patients.
- To investigate the impact of lactose restriction on thyroid function in HT patients with LI.
Main Methods:
- Eighty-three HT patients on L-thyroxine (LT4) therapy were assessed for LI using lactose tolerance tests.
- Patients diagnosed with LI underwent an 8-week lactose-restricted diet.
- Thyroid-stimulating hormone (TSH) levels were monitored before and after the dietary intervention.
Main Results:
- Lactose intolerance was diagnosed in 75.9% of HT patients.
- A significant decrease in TSH levels was observed in euthyroid and subclinical hypothyroid HT patients with LI after adopting a lactose-restricted diet (P<0.05).
- No significant changes in TSH levels were noted in HT patients without LI.
Conclusions:
- Lactose intolerance is highly prevalent in patients with Hashimoto's thyroiditis.
- Lactose restriction can lead to reduced TSH levels in HT patients with LI.
- Consider LI in HT patients with difficult-to-manage hypothyroidism, irregular TSH, or resistance to LT4 therapy.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
